Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ritz

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Plos Computational Biology|August 13, 2013
Evolutionary evidence for alternative structure in RNA sequence co-variationJustin Ritz, Joshua S Martin, Alain Laederach
BMC Genomics|July 5, 2012
Evaluating our ability to predict the structural disruption of RNA by SNPsJustin Ritz, Joshua S Martin, Alain Laederach
PLOS Global Public Health|January 4, 2024
Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trialsMcNeil Ngongondo, Justin Ritz, Michael D Hughes, et al.
RNA (New York, N.Y.)|November 24, 2011
Structural effects of linkage disequilibrium on the transcriptomeJoshua S Martin, Matthew Halvorsen, Lauren Davis-Neulander, et al.
Viruses|April 27, 2017
Structure-Function Model for Kissing Loop Interactions That Initiate Dimerization of Ty1 RNAEric R Gamache, Jung H Doh, Justin Ritz, et al.
Cell Reports|May 24, 2016
The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like RegionKaryn Schmidt, Cailin E Joyce, Frank Buquicchio, et al.
Cell Reports|May 23, 2019
The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21Karyn Schmidt, Johanna S Carroll, Elaine Yee, et al.
The Journal of Infectious Diseases|May 29, 2019
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS)Rajesh T Gandhi, Karen T Tashima, Laura M Smeaton, et al.
AIDS Research and Therapy|January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanceRobert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.
The Journal of Infectious Diseases|August 31, 2023
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment TrialKara W Chew, Carlee Moser, Eunice Yeh, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Plos Computational Biology|August 13, 2013
Evolutionary evidence for alternative structure in RNA sequence co-variationJustin Ritz, Joshua S Martin, Alain Laederach
BMC Genomics|July 5, 2012
Evaluating our ability to predict the structural disruption of RNA by SNPsJustin Ritz, Joshua S Martin, Alain Laederach
PLOS Global Public Health|January 4, 2024
Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trialsMcNeil Ngongondo, Justin Ritz, Michael D Hughes, et al.
RNA (New York, N.Y.)|November 24, 2011
Structural effects of linkage disequilibrium on the transcriptomeJoshua S Martin, Matthew Halvorsen, Lauren Davis-Neulander, et al.
Viruses|April 27, 2017
Structure-Function Model for Kissing Loop Interactions That Initiate Dimerization of Ty1 RNAEric R Gamache, Jung H Doh, Justin Ritz, et al.
Cell Reports|May 24, 2016
The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like RegionKaryn Schmidt, Cailin E Joyce, Frank Buquicchio, et al.
Cell Reports|May 23, 2019
The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21Karyn Schmidt, Johanna S Carroll, Elaine Yee, et al.
The Journal of Infectious Diseases|May 29, 2019
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS)Rajesh T Gandhi, Karen T Tashima, Laura M Smeaton, et al.
AIDS Research and Therapy|January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanceRobert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.
The Journal of Infectious Diseases|August 31, 2023
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment TrialKara W Chew, Carlee Moser, Eunice Yeh, et al.
Pageof 6